Skip to content

Study · Measured the body's own peptide · 1983

1 result

Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignancies.

Hersh EM, Mansell PW, Reuben JM, Rios A, Newell GR, Goldstein AL, Lynch K

Diagnostic immunology1 Jan 1983Cited by 14 (Europe PMC)

PMID6238750 (opens in a new tab)PepBankPUB-06238750

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In thirty-three patients with acquired immune deficiency syndrome, the majority had elevated serum thymosin alpha‑1.

    In plain wordsIn patients with AIDS, most had raised levels of the body's own thymosin alpha‑1 in blood.

    Outcome
    IncreaseSerum thymosin alpha 1 level in AIDS
    Study

    n = 33

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In thirty-three patients with the acquired immune deficiency syndrome, the majority showed an inverted helper:suppressor ratio, elevated serum thymosin alpha 1, and elevated serum lysozyme levels.
    1 context sentence
    Summary · context
    In this paper we have focused on the ratio of helper to suppressor cells in patients with the acquired immune deficiency syndrome and in patients with malignancy.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.